You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Suppliers and packagers for NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Inforlife NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 215700 NDA WG Critical Care, LLC 44567-640-10 10 BAG in 1 CARTON (44567-640-10) / 250 mL in 1 BAG (44567-640-01) 2022-09-15
Inforlife NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 215700 NDA WG Critical Care, LLC 44567-641-10 10 BAG in 1 CARTON (44567-641-10) / 250 mL in 1 BAG (44567-641-01) 2022-09-15
Inforlife NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 215700 NDA WG Critical Care, LLC 44567-642-10 10 BAG in 1 CARTON (44567-642-10) / 250 mL in 1 BAG (44567-642-01) 2022-09-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Norepinephrine Bitartrate in 0.9% Sodium Chloride

Last updated: July 29, 2025

Introduction
Norepinephrine bitartrate in 0.9% sodium chloride is a critical vasopressor widely used in emergency medicine and intensive care for the management of hypotension and shock states. As a highly regulated and sensitive pharmaceutical, sourcing reliable suppliers that meet stringent quality standards is paramount for healthcare providers, distributors, and manufacturers. This report details the leading global suppliers, regulatory considerations, and strategic sourcing insights for norepinephrine bitartrate in saline infusion solutions.


Overview of Norepinephrine Bitartrate in Saline

Norepinephrine (noradrenaline) is a naturally occurring catecholamine with potent vasoconstrictive properties. In clinical settings, it is typically supplied as a sterile solution of norepinephrine bitartrate in 0.9% sodium chloride (saline) for intravenous administration. The formulation preserves stability and facilitates rapid infusion to optimize hemodynamic parameters. Due to its potency, manufacturing processes are tightly regulated to ensure purity, stability, and sterility.


Key Global Suppliers

1. Pfizer Inc.

Overview:
Pfizer is a leading global pharmaceutical corporation with extensive capabilities in sterile injectables, including norepinephrine formulations. Their production facilities adhere to strict regulatory standards like the FDA’s Current Good Manufacturing Practice (CGMP). They offer norepinephrine in various concentrations, including premixed saline solutions.

Product Details:

  • Strength: 4 mg/4 mL or 8 mg/4 mL vials.
  • Packaging: Prefilled syringes, vials.
  • Regulatory Status: Approved by the FDA, EMA, and other major health authorities.

Sources & Distribution:
Pfizer supplies through authorized distributors and direct sales channels, often serving large hospitals and healthcare systems.

2. Bachem Holding AG

Overview:
Specializing in peptide and sterile injectable manufacturing, Bachem supplies customized norepinephrine products to biotech and pharmaceutical firms, emphasizing high purity standards and supply security.

Product Details:

  • Focus on bulk manufacturing for OEMs rather than direct retail.
  • Custom formulations available.

Regulatory Compliance:
Manufactures under strict CGMP standards, with dedicated cytotoxic and sterile production suites.

3. West-Ward Pharmaceuticals (a Korean company, part of Hikma Pharmaceuticals)

Overview:
West-Ward specializes in sterile injectable drugs, including vasopressors. They maintain robust supply chains across North America and Asia, enabling widespread distribution.

Product Details:

  • Concentration: Typically 4 mg/4 mL.
  • Packaging: Vials and flexible containers.
  • Regulatory standards: Compliant with U.S. FDA, MHRA, and other global agencies.

4. Sandoz (Novartis division)

Overview:
Sandoz offers a range of sterile injectables, including norepinephrine solutions, established in multiple markets. Their manufacturing sites comply with international Good Manufacturing Practices.

Product Details:

  • Concentrations: Various strengths suitable for different infusion protocols.
  • Formulations: Ready-to-use vials.

5. Teva Pharmaceutical Industries Ltd.

Overview:
Teva, a prominent generic pharmaceutical manufacturer, supplies norepinephrine in saline, primarily to North American markets.

Product Details:

  • Packaging: Single-dose vials and multidose containers.
  • Regulatory: Approved by FDA and other agencies.

Additional Suppliers

Small and mid-sized manufacturers often operate regionally or contract manufacturing organizations (CMOs), providing customized formulations to meet local procurement needs. Examples include local generics producers in India, China, and Eastern Europe, which often supply to regional markets.


Regulatory and Quality Considerations

Suppliers must adhere to numerous regulatory standards, including FDA (U.S.), EMA (Europe), and other country-specific agencies. Quality assurance involves validation of sterile manufacturing, stability testing, endotoxin levels, and impurity profiles. Suppliers with robust quality systems tend to have reliable supply chains critical for emergency and ongoing clinical needs.

Certification & Compliance

  • GMP Certification: Essential for legal compliance and safety assurance.
  • ISO Certifications: Typically ISO 9001 and ISO 13485 for quality management.

Supply Chain Dynamics and Risk Factors

The market for norepinephrine solutions is characterized by high demand amidst supply constraints in certain regions, especially during global crises like the COVID-19 pandemic. Limited manufacturing capacity and regulatory hurdles can create shortages, emphasizing the importance of strategic sourcing and inventory management. Contract manufacturing partnerships and regional suppliers can mitigate risks, but quality assurance remains vital.


Strategies for Procurement

Healthcare providers and distributors should consider the following approaches:

  • Collaborate with multiple authorized suppliers to diversify sources.
  • Secure supply agreements with proven manufacturers that adhere to international regulatory standards.
  • Monitor regulatory updates to ensure compliance and anticipate potential supply disruptions.
  • Establish inventory buffers for critical use to prevent shortages.

Conclusion

Reliable procurement of norepinephrine bitartrate in 0.9% sodium chloride hinges on engaging with established manufacturers with proven quality standards. Pfizer, West-Ward, Sandoz, Teva, and Bachem are prominent global suppliers offering various strengths and packaging suited for clinical needs. Ensuring supply chain resilience involves strategic sourcing, rigorous oversight of quality certifications, and proactive inventory management.


Key Takeaways

  • Leading suppliers include Pfizer, West-Ward, Sandoz, Teva, and Bachem, each with global manufacturing capabilities.
  • Regulatory compliance, including GMP certification, is essential for ensuring product safety and efficacy.
  • The supply landscape is influenced by manufacturing capacity constraints, regional regulatory requirements, and global supply chain disruptions.
  • Diversification of suppliers and regional sourcing can mitigate shortages.
  • Strategic procurement and inventory management are critical for the consistent availability of norepinephrine solutions.

FAQs

1. How do I verify the authenticity of norepinephrine solutions from suppliers?
Confirm that the supplier holds valid GMP certification and that products carry appropriate regulatory approval labels (FDA, EMA, etc.). Request batch certificates and quality assurance documentation.

2. What factors should be considered when choosing a supplier for norepinephrine in saline?
Consider regulatory compliance, product stability, packaging convenience, supplier reputation, lead times, and regional availability.

3. Are there regional differences in suppliers for norepinephrine solutions?
Yes. While global suppliers like Pfizer and Sandoz serve multiple markets, regional manufacturers may be more prominent in Asia, Eastern Europe, or developing markets, often providing cost-effective options.

4. How does supply chain disruption impact clinical use of norepinephrine?
Disruptions can lead to shortages, impacting emergency and critical care. Maintaining relationships with multiple suppliers and stockpiling where appropriate can mitigate this risk.

5. What emerging trends are affecting the supply of norepinephrine solutions?
Increasing regulatory scrutiny, manufacturing consolidation, and rising demand for sterile injectables are shaping supply dynamics. Additionally, innovations in formulation and regional manufacturing capacity expansion are anticipated to improve supply stability.


References

[1] U.S. Food and Drug Administration (FDA). “List of Approved Drug Products.” https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Medicines Agency (EMA). "Manufacturers and Suppliers Database." https://www.ema.europa.eu/
[3] Pfizer Inc. Product Information.
[4] Sandoz International GmbH. Product Portfolio.
[5] Teva Pharmaceuticals. Approvals and Certifications.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.